APOLLOHOSPHospital
Apollo Hospitals Enterprise Ltd — Cash Flow Statement
₹7419.00
-0.39%
Apollo Hospitals Enterprise Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 423.70 Cr | 783.40 Cr | 248.40 Cr | 1.04K Cr | — |
| Repayment Of Debt | -442.20 Cr | -253.90 Cr | -516.10 Cr | -737.20 Cr | — |
| Issuance Of Debt | 2.59K Cr | 707.40 Cr | 584.90 Cr | 425.70 Cr | — |
| Capital Expenditure | -1.71K Cr | -1.14K Cr | -1.13K Cr | -657.20 Cr | — |
| End Cash Position | 578.10 Cr | 505.50 Cr | 433.40 Cr | 546.50 Cr | — |
| Beginning Cash Position | 505.50 Cr | 433.40 Cr | 546.50 Cr | 388.70 Cr | — |
| Changes In Cash | 72.60 Cr | 71.90 Cr | -126.70 Cr | 57.20 Cr | — |
| Financing Cash Flow | 1.32K Cr | -311.10 Cr | -633.00 Cr | -791.60 Cr | — |
| Net Other Financing Charges | 44.50 Cr | -11.90 Cr | — | -1.00 Cr | -0.40 Cr |
| Interest Paid Cff | -301.80 Cr | -302.90 Cr | -251.30 Cr | -255.20 Cr | — |
| Cash Dividends Paid | -273.20 Cr | -215.70 Cr | -255.20 Cr | -43.30 Cr | — |
| Net Issuance Payments Of Debt | 2.14K Cr | 453.50 Cr | 68.80 Cr | -311.50 Cr | — |
| Net Long Term Debt Issuance | 2.14K Cr | 453.50 Cr | 68.80 Cr | -311.50 Cr | — |
| Long Term Debt Payments | -442.20 Cr | -253.90 Cr | -516.10 Cr | -737.20 Cr | — |
| Long Term Debt Issuance | 2.59K Cr | 707.40 Cr | 584.90 Cr | 425.70 Cr | — |
| Investing Cash Flow | -3.38K Cr | -1.54K Cr | -870.60 Cr | -847.20 Cr | — |
| Interest Received Cfi | 84.40 Cr | 39.30 Cr | 44.20 Cr | 35.90 Cr | — |
| Dividends Received Cfi | 9.80 Cr | 0.00 | 5.00 Cr | 0.00 | — |
| Net Investment Purchase And Sale | -1.76K Cr | -440.30 Cr | 256.30 Cr | -141.30 Cr | — |
| Sale Of Investment | 1.82K Cr | 816.70 Cr | 1.25K Cr | 1.40K Cr | — |
| Purchase Of Investment | -3.57K Cr | -1.26K Cr | -992.00 Cr | -1.54K Cr | — |
| Net Business Purchase And Sale | 0.00 | -3.70 Cr | -49.90 Cr | -101.00 Cr | — |
| Purchase Of Business | 0.00 | -3.70 Cr | -49.90 Cr | -101.00 Cr | — |
| Net PPE Purchase And Sale | -1.70K Cr | -1.13K Cr | -1.12K Cr | -651.80 Cr | — |
| Sale Of PPE | 14.90 Cr | 1.90 Cr | 4.10 Cr | 5.40 Cr | — |
| Purchase Of PPE | -1.71K Cr | -1.14K Cr | -1.13K Cr | -657.20 Cr | — |
| Operating Cash Flow | 2.14K Cr | 1.92K Cr | 1.38K Cr | 1.70K Cr | — |
| Taxes Refund Paid | -486.00 Cr | -466.70 Cr | -382.00 Cr | -204.30 Cr | — |
| Change In Working Capital | -603.90 Cr | -192.80 Cr | -450.00 Cr | -359.20 Cr | — |
| Change In Other Current Liabilities | 70.20 Cr | 4.20 Cr | 32.40 Cr | -79.20 Cr | — |
| Change In Other Current Assets | 17.00 Cr | -238.40 Cr | -287.90 Cr | -6.80 Cr | — |
| Change In Payable | -128.00 Cr | 410.80 Cr | 280.90 Cr | 253.00 Cr | — |
| Change In Inventory | -21.00 Cr | -69.20 Cr | 41.90 Cr | -175.80 Cr | — |
| Change In Receivables | -590.50 Cr | -333.40 Cr | -536.40 Cr | -341.90 Cr | — |
| Other Non Cash Items | 363.70 Cr | 404.50 Cr | 336.40 Cr | 414.10 Cr | — |
| Stock Based Compensation | 112.70 Cr | 87.50 Cr | 76.00 Cr | 2.60 Cr | — |
| Provisionand Write Offof Assets | 62.90 Cr | 73.80 Cr | 51.20 Cr | -1.80 Cr | — |
| Deferred Tax | 526.30 Cr | 445.50 Cr | 256.20 Cr | 477.00 Cr | — |
| Depreciation And Amortization | 757.50 Cr | 687.00 Cr | 615.40 Cr | 600.70 Cr | — |
| Amortization Cash Flow | 67.50 Cr | 47.50 Cr | 40.40 Cr | 40.80 Cr | — |
| Depreciation | 690.00 Cr | 639.50 Cr | 575.00 Cr | 559.90 Cr | — |
| Gain Loss On Investment Securities | -77.30 Cr | -37.40 Cr | -28.50 Cr | -43.50 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.10 Cr | 0.10 Cr | -0.30 Cr | -0.60 Cr | — |
| Gain Loss On Sale Of PPE | 6.30 Cr | 3.60 Cr | 15.00 Cr | 4.00 Cr | — |
| Net Income From Continuing Operations | 1.51K Cr | 935.00 Cr | 844.30 Cr | 1.11K Cr | — |
| Issuance Of Capital Stock | — | 2.50 Cr | 4.50 Cr | 0.00 | 1.15K Cr |
| Other Cash Adjustment Outside Changein Cash | — | 0.20 Cr | 13.60 Cr | 100.60 Cr | -16.70 Cr |
| Net Common Stock Issuance | — | 2.50 Cr | 4.50 Cr | 0.00 | 1.15K Cr |
| Common Stock Issuance | — | 2.50 Cr | 4.50 Cr | 0.00 | 1.15K Cr |
| Common Stock Dividend Paid | — | — | -255.20 Cr | -43.30 Cr | -38.26 Cr |
| Gain Loss On Sale Of Business | — | — | 0.00 | 0.00 | -35.40 Cr |
| Sale Of Business | — | — | — | 0.00 | 527.80 Cr |
| Net Other Investing Changes | — | — | — | — | 527.80 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Apollo Hospitals Enterprise Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.